Renoprotection by ACE inhibitors after severe hemolytic uremic syndrome

Pediatric Nephrology

Volumn 19, Issue 6, 2004, Pages 688-690

  Van Dyck, Maria ^a   Proesmans, Willem ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Angiotensin convering enzyme inhibitors; Hemolytic uremic syndrome; Long term outcome; Renoprotection

Indexed keywords

ATENOLOL; CAPTOPRIL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BLOOD PRESSURE REGULATION; BODY HEIGHT; BODY WEIGHT; CHILD DEVELOPMENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS; DISEASE SEVERITY; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMOLYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERTENSION; KIDNEY DISEASE; MEDICAL ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEINURIA; THROMBOCYTOPENIA;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAPTOPRIL; CHILD, PRESCHOOL; CREATININE; ENALAPRIL; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; HYPERTENSION; KIDNEY; PROTEINURIA; TIME FACTORS;

EID: 2942657338     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-004-1451-y     Document Type: Article

References (14)

1. Brenner BM (2002) Remission of renal disease: recounting the challenge, acquiring the goal. J Clin Invest 110:1753-1758
2. Kaplan BS, Proesmans W (1987) The hemolytic uremic syndrome of childhood and its variants. Semin Hematol 24:148-160
3. Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, Masschio G, Brenner BM, Kamper A, Zucchelli P, Becker G, Himmelmann A, Bannister K, Landais P, Shahinfar S, Jong PE de, Zeeuw D de, Lau J, Levey AS (2001) Angiotensin-converting enzyme inhibitors and progression of nondiabetic disease. A meta-analysis of patient-level data. Ann Intern Med 135:73-87
4. Monnens LAH, Donckerwolcke RAMG (1998) Nierziekten en hypertensie. In: Van den Brande JL, Heymans HSA, Monnens LAH (eds) Kindergeneeskunde, 3rd edn. Elsevier, pp 479-498
5. Cook J, Daneman D, Spino M, Sochett E, Perlman K, Balfe JW (1990) Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitus. J Pediatr 117:39-45
6. Yüksel H, Darcan S, Kabasakal C, Cura A, Mir S, Mavi E (1998) Effect of enalapril on proteinuria, phosphaturia and calciuria in insulin-dependent diabetes. Pediatr Nephrol 12: 648-650
7. Proesmans W, Van Wambeke I, Van Dyck M (1996) Long-term therapy with enalapril in patients with nephrotic-range proteinuria. Pediatr Nephrol 10:587-589
8. Delucchi A, Cano F, Rodriguez E, Wolff E, Gonzalez X, Cumsille MA (2000) Enalapril and prednisone in children with nephrotic-range proteinuria. Pediatr Nephrol 14:1088-1091
9. Lama G, Salsano ME, Pedulla M, Grassia C, Ruocco G (1998) Angiotensin-converting enzyme inhibitors and reflux nephropathy: 2 year follow-up. Pediatr Nephrol 11:714-718
10. Proesmans W, Knockaert H, Trouet D (2000) Enalapril in pediatric patients with Alport syndrome: 2 years' experience. Eur J Pediatr 159:430-433
11. Monnens L, Drayer J, De Jong M (1981) Malignant hypertension in a child with hemolytic uremic syndrome treated with captopril. Acta Paediatr Scand 70:583-585
12. Griswold W, McNeal R, O'Connor D, Reznik V, Mendoza S (1982) Oral converting enzyme inhibitor in malignant hypertension. Arch Dis Child 57:235-237
13. Pennesi M, Torre G (2000) Angiotensin-converting enzyme inhibition in non-diabetic nephropathy with non-nephrotic proteinuria. Pediatr Nephrol 14:438
14. Wells T, Rippley R, Hogg R, Sakarcan A, Blowey D, Walson P, Vogt B, Delucchi A, Lo MW, Hand E, Panebianco D, Shaw W, Shahinfar S (2001) The pharmacokinetics of enalapril in children and infants with hypertension. J Clin Pharmacol 41:1064-1074